Brief: Brii Biosciences Ltd Says Tsb Therapeutics (Beijing) Is Partnering With Sinopharm Holding
30/03/2022 02:36
March 30 (Reuters) - Brii Biosciences Ltd 2137.HK :
* TSB THERAPEUTICS (BEIJING) CO IS PARTNERING WITH SINOPHARM
HOLDING CO.
* PARTNERSHIP TO ADVANCE STOCKPILING, CHANNEL DISTRIBUTION
AND
ACCESS OF CO'S LONG-ACTING NEUTRALIZING MONOCLONAL ANTIBODY
THERAPY
Source text for Eikon: ID:nHKSlKd1K
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR